---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-283007"
form_type: "8-K"
ticker: "SMNR"
cik: "0001913577"
company_name: "Semnur Pharmaceuticals, Inc."
filed_at: "2026-06-25T21:03:49+00:00"
generated_at: "2026-06-25T21:06:19.677463+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Semnur stockholders elect director, ratify auditor, approve 2025 equity plans at annual meeting

## Summary
- Jay Chun, M.D., Ph.D. elected Class I director with 200,166,258 for, 3,804 withheld, 137,409 broker non-votes.
- Ratification of Pipara & Co LLP as auditor for FY 2026: 200,307,425 for, 46 against, 0 abstentions.
- 2025 Equity Incentive Plan approved: 200,166,256 for, 269 against, 3,537 abstentions, 137,409 broker non-votes.
- 2025 Employee Stock Purchase Plan approved: 200,166,255 for, 270 against, 3,537 abstentions, 137,409 broker non-votes.

## SEC filing metadata
- accession: 0001193125-26-283007
- form_type: 8-K
- ticker: SMNR
- cik: 0001913577
- company_name: Semnur Pharmaceuticals, Inc.
- filed_at: 2026-06-25T21:03:49+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1913577/000119312526283007/0001193125-26-283007-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1913577/000119312526283007/smnr-20260625.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-283007
- JSON: https://secwatch.observer/filing/0001193125-26-283007.json
- Plain text: https://secwatch.observer/filing/0001193125-26-283007.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.